In one paragraphArticle in Clinical journal of the American Society of Nephrology : CJASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Sagar U NigwekarDivision of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-6750-0072 Laura M DemberRenal, Electrolyte and Hypertension Division, Department of Medicine, Department of Biostatistics, Epidemiology and Informatics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.ORCID 0000-0002-9735-7473 Sahir KalimDivision of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-1746-5790 David M CharytanNephrology Division, Department of Medicine, NYU Grossman School of Medicine, New York, New York.ORCID 0000-0002-7695-3583 Natalie KuzlaClinical Research Collaboration Unit, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Paul L KimmelDepartment of Medicine, George Washington University, Washington, DC.
Daniel CukorNephrology Division, Department of Medicine, NYU Grossman School of Medicine, New York, New York.
Puneet MishraDivision of Pain Medicine, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.ORCID 0000-0002-8238-8584 Kimberly SilvaDivision of Nephrology, University of Illinois Hospital and Health Sciences Center, Chicago, Illinois.ORCID 0000-0001-5734-3045 Alana D SteffenDepartment of Population Health Nursing Science, University of Illinois Chicago, Chicago, Illinois.ORCID 0000-0003-4292-6138 Svetlana VassilievaDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.ORCID 0009-0003-7739-5434 Joey WilliamsMinneapolis, Minnesota.
James B WetmoreDivision of Nephrology, Hennepin Healthcare and Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Funding
UPENN Scientific and Data Research Center for the HOPE Consortium to Reduce Pain and Opioid Use in HemodialysisÃÂÃÂ U01DK123813 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI DEMBER, LAURA M, FARRAR, JOHN T · 2019 to 2024
$6.6MRandomized ESRD Trial COmparing CBT alone VERsus with buprenorphine (RECOVER)U01DK123786 · NIDDK · UNIVERSITY OF WASHINGTON · PI CUKOR, DANIEL, MEHROTRA, RAJNISH · 2019 to 2022
$3.4MPain Reduction and Opioid MedIcation Safety in ESRD (PROMISE) studyU01DK123812 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JHAMB, MANISHA, LIEBSCHUTZ, JANE M · 2019 to 2020
$3.1MUniversity of Illinois at Chicago Hemodialysis Opioid Prescription Effort (HOPE) Clinical CenterU01DK123787 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOORENBOS, ARDITH Z, FISCHER, MICHAEL J. · 2019 to 2020
$3.0MPain, Opioids, and ESRD risk reduction with Mindfulness and Buprenorphine (POEM-B): A 3-arm multi-site randomized trial in hemodialysis patientsU01DK123814 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHARYTAN, DAVID M, LEE, JOSHUA D · 2019 to 2019
$2.9MVanderbilt-West Virginia (VWV) Collaborative: A HOPE Consortium Clinical CenterU01DK123821 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CAVANAUGH, KERRI · 2019 to 2019
$2.9MThe Hemodialysis Opioid Prescription Effort ConsortiumU01DK123816 · NIDDK · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI BART, GAVIN, JOHANSEN, KIRSTEN L. · 2019 to 2019
$2.6MVideo-Telecare Collaborative Pain Management to Improve Function and Reduce Opioid Risk in Patients with End Stage Renal Disease Receiving HemodialysisU01DK123817 · NIDDK · YALE UNIVERSITY · PI BECKER, WILLIAM C, CROWLEY, SUSAN T · 2019 to 2019
$2.6MReducing Chronic Pain and Opioid Use in Hemodialysis PatientsU01DK123818 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KALIM, SAHIR, NIGWEKAR, SAGAR · 2019 to 2019
$2.4MNIDDK U01DK123786, U01DK123787, U01DK123812, U01DK123813, U01DK123814, U01DK123816, U01DK123817, U01DK123818, U01DK123821NIDDK NIH HHS U01 DK123786NIDDK NIH HHS U01DK123786, U01DK123787, U01DK123812, U01DK123813, U01DK123814, U01DK123816, U01DK123817, U01DK123818, U01DK123821NIDDK NIH HHS U01 DK123787NIDDK NIH HHS U01 DK123812NIDDK NIH HHS U01 DK123813NIDDK NIH HHS U01 DK123814NIDDK NIH HHS U01 DK123816NIDDK NIH HHS U01 DK123817NIDDK NIH HHS U01 DK123818NIDDK NIH HHS U01 DK123821
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
ESKDhyperphosphatemiavascular calcification
Identifiers
PMID41414940
PMCPMC13383668
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390